Association of HLA Alleles with Cephalosporin Allergy in the Taiwanese Population

Abstract

Background: Cephalosporin antibiotics are widely used in clinical settings, but they can cause hypersensitivity reactions, which may be influenced by genetic factors such as the expression of Human leukocyte antigen (HLA) molecules. This study aimed to investigate whether specific HLA alleles were associated with an increased risk of adverse reactions to cephalosporins among individuals in the Taiwanese population. Methods: This retrospective case-control study analyzed data from the Taiwan Precision Medicine Initiative (TPMI) on 27,933 individuals who received cephalosporin exposure and had HLA allele genotyping information available. Using logistic regression analyses, we examined the associations between HLA genotypes, comorbidities, allergy risk, and severity. Results: Among the study population, 278 individuals had cephalosporin allergy and 2,780 were in the control group. Our results indicated that certain HLA alleles, including B55:02 (OR = 1.76, 95% CI: 1.18-2.61, p=0.005), C01:02 (OR = 1.36, 95% CI: 1.05-1.77, p=0.018), and DQB106:09 (OR = 2.58, 95% CI: 1.62-4.12, p<0.001), were significantly associated with an increased risk of cephalosporin allergy reactions. Additionally, the HLA-C01:02 allele genotype was significantly associated with a higher risk of severe allergy (OR=2.33, 95% CI: 1.05-5.15, p=0.04). Conclusion: This study identified significant associations between HLA alleles and an increased risk of cephalosporin allergy, which can aid in early detection and prediction of adverse drug reactions to cephalosporins. Furthermore, our study highlights the importance of HLA typing in drug safety and expanding our knowledge of drug hypersensitivity syndromes.